List view / Grid view
In this issue: novel approaches to produce radiolabelled antibodies, the use of CRISPR/Cas9 to accelerate the development of targeted therapies and utilisation of stem cells to study the effects of cannabis on neuronal development.
A novel way to create Expanded Potential Stem Cells has generated opportunities to research regenerative medicine.
Arizona company claims their products can treat Lyme disease, diabetes, Parkinson’s disease and more, but have not been approved for any use.
Researchers use stem cell-based disease models to pinpoint gene linked to impaired memory in Down syndrome.
A new way to cleanly separate out cancer cells from a blood sample will enable comprehensive genetic profiling of the cancer cells.
Integrating hardware, software and fluorescent labels for optimised HCA assay development.
Introducing the CellInsight CX7 LZR High-Content Analysis Platform - an updated version of our CellInsight CX7 instrument with advanced laser technology.
From the B-27 Plus Neuronal Culture System to fluorescent probes for cell analysis. Publication history of B-27 supplements demonstrates that researchers are expanding its use, far beyond the long-term culture of rat hippocampal and cortical neurons.
Scientists identify 'wake-up' signal for deep-sleeping neural stem cells to potentially aid in the treatment for neurological disorders.
HCA platforms automate image capture and data analysis, giving researchers the sample sizes and precise quantitation tools required for research.
Harvard-led research boosts the yield of insulin-producing cells for diabetes therapy.
Researchers have discovered that certain skin-related stem cells could help in treating neurogenerative diseases.
High-content analysis app note: Phenotypic fingerprint of cellular function following gene editing by high-throughput imaging acquisition and analysis.
High-content analysis: monitoring neurite morphology and synapse formation in primary neurons for neurotoxicity assessments and drug screening.
The findings offer clues that could one day lead to treatments for the neurological condition...
